ClinicalTrials.govpublic full text
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
beta-lactam antibiotics, therapeutic drug monitoring, toxicity, efficacy, imipenem, meropenem
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 18653 · SHA-256 17c3746fc8cd5ac2
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.